# Study to Learn About Relapse Prevention of Hypericumextract (a Drug Based on the Plant St. John Wort) in Outpatients Suffering From Moderate Depressive Episodes

> **NCT04315597** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 398 (actual)

## Conditions studied

- Moderate Depressive Episodes (Major Depression)

## Interventions

- **DRUG:** Laif® 900, BAY98-7108
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04315597
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03-03
- **Primary completion:** 2011-11-22
- **Final completion:** 2011-11-22
- **Target enrollment:** 398 (ACTUAL)
- **Last updated:** 2020-03-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04315597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04315597, "Study to Learn About Relapse Prevention of Hypericumextract (a Drug Based on the Plant St. John Wort) in Outpatients Suffering From Moderate Depressive Episodes". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT04315597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*